Matches in Wikidata for { <http://www.wikidata.org/entity/Q74225962> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q74225962 description "artikull shkencor i botuar më 01 janar 1997" @default.
- Q74225962 description "artículu científicu espublizáu en xineru de 1997" @default.
- Q74225962 description "im Jahr 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74225962 description "scientific article published on 01 January 1997" @default.
- Q74225962 description "wetenschappelijk artikel" @default.
- Q74225962 description "наукова стаття, опублікована в січні 1997" @default.
- Q74225962 name "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 name "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 name "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682" @default.
- Q74225962 type Item @default.
- Q74225962 label "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 label "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 label "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682" @default.
- Q74225962 prefLabel "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 prefLabel "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 prefLabel "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682" @default.
- Q74225962 P1433 Q74225962-32077850-8FA7-4003-AC0E-9D100CF87ABC @default.
- Q74225962 P1476 Q74225962-F620A112-A47C-4245-AC2E-6303AB2A0AC8 @default.
- Q74225962 P2093 Q74225962-363ABC32-2033-4C19-84D4-D52568BD00B0 @default.
- Q74225962 P2093 Q74225962-74FBE2B5-0CDD-4892-9C7A-DA252F8F32E0 @default.
- Q74225962 P2093 Q74225962-9DA74FA7-14F8-4220-AAAC-C2359430C7BC @default.
- Q74225962 P2093 Q74225962-AE284DC1-C0FA-4C3E-9DF7-70CE54A75644 @default.
- Q74225962 P304 Q74225962-76EB0009-481A-4E1E-9E10-5F392CAE5340 @default.
- Q74225962 P31 Q74225962-79033AE1-A69C-4D61-B983-EBA02DC8A552 @default.
- Q74225962 P356 Q74225962-21372895-B727-4575-B069-D33FF3839C80 @default.
- Q74225962 P478 Q74225962-31C14848-B99E-4187-A53B-8B65CCD1392D @default.
- Q74225962 P577 Q74225962-DABDF1FE-C9BC-459E-8B54-084E54B8AE95 @default.
- Q74225962 P698 Q74225962-615B8F51-6EDC-433B-94A9-069EF6F72170 @default.
- Q74225962 P356 000179262 @default.
- Q74225962 P698 9477040 @default.
- Q74225962 P1433 Q27711280 @default.
- Q74225962 P1476 "Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol" @default.
- Q74225962 P2093 "E Bouskela" @default.
- Q74225962 P2093 "E Svensjö" @default.
- Q74225962 P2093 "F Z Cyrino" @default.
- Q74225962 P2093 "L Lerond" @default.
- Q74225962 P304 "18-20" @default.
- Q74225962 P31 Q13442814 @default.
- Q74225962 P356 "10.1159/000179262" @default.
- Q74225962 P478 "17 Suppl 1" @default.
- Q74225962 P577 "1997-01-01T00:00:00Z" @default.
- Q74225962 P698 "9477040" @default.